As of today (2024-04-18), Zimmer Biomet Holdings's share price is $120.01.
Zimmer Biomet Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.55. Hence, Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow Ratio for today is 15.90.
The historical rank and industry rank for Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:
ZBH'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.54 Med: 17.15 Max: 35.94
Current: 15.9
During the past 13 years, Zimmer Biomet Holdings's highest Price-to-Operating-Cash-Flow Ratio was 35.94. The lowest was 10.54. And the median was 17.15.
Zimmer Biomet Holdings's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $2.82.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.55.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Zimmer Biomet Holdings was 23.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -3.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.00% per year.
During the past 13 years, Zimmer Biomet Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.90% per year. The lowest was -11.90% per year. And the median was 8.90% per year.
Zimmer Biomet Holdings Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Zimmer Biomet Holdings Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
18.93 |
25.69 |
17.30 |
20.87 |
16.14 |
|
Zimmer Biomet Holdings Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.87 |
20.06 |
22.67 |
19.06 |
16.14 |
Competitive Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Price-to-Operating-Cash-Flow Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow falls into.
Zimmer Biomet Holdings Price-to-Operating-Cash-Flow Calculation
Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 120.01 | / | 7.549 |
| = | 15.90 |
Zimmer Biomet Holdings's Share Price of today is $120.01.
Zimmer Biomet Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.55.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description
Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Executives
| Syed A. Jafry |
director |
345 E. MAIN STREET, WARSAW IN 46580 |
| Sreelakshmi Kolli |
director |
C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131 |
| Christopher B Begley |
director |
|
| Robert Hagemann |
director |
3 GIRALDA FARMS, MADISON NJ 07940 |
| Michael W Michelson |
director |
2800 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025 |
| Betsy J Bernard |
director |
711 HIGH STREET, DES MOINES IA 50392-0300 |
| Arthur J Higgins |
director |
C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580 |
| Chad F Phipps |
officer: Assoc. Gen. Counsel, Corp. Sec |
C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580 |
| Zuilen Wilfred Van |
officer: Pres, Europe, M. East & Africa |
345 E. MAIN STREET, WARSAW IN 46580 |
| Paul A Stellato |
officer: VP, Controller & CAO |
C/O XYLEM INC, 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573 |
| Sang Yi |
officer: President, Asia Pacific |
345 E. MAIN STREET, WARSAW IN 46580 |
| Lori Winkler |
officer: SVP and CHRO |
345 E. MAIN STREET, WARSAW IN 46580 |
| Rachel Ellingson |
officer: SVP & CSO |
345 E MAIN STREET, WARSAW K7 46580 |
| Bryan C Hanson |
director, officer: President and CEO |
ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580 |
| Aure Bruneau |
officer: Group President |
345 E. MAIN STREET, WARSAW IN 46580 |
Zimmer Biomet Holdings (Zimmer Biomet Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZBH has been successfully added to your